# FDA EIR - Eli Lilly & Company - January 17, 2020

Source: https://www.keypedia.com/records/eir/eli-lilly-company/00535940-b628-4bcd-aa01-17eb95be770e

> FDA EIR for Eli Lilly & Company on January 17, 2020. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Eli Lilly & Company
- Inspection Date: 2020-01-17

## Related Documents

- [483 - 2023-06-16](https://www.keypedia.com/records/483/eli-lilly-company/ad3d5c22-c165-4f63-91cc-163c31217be2)
- [483 - 2023-10-06](https://www.keypedia.com/records/483/eli-lilly-company/f0349542-8a47-4147-9164-7ecacf1fcd4e)
- [483 - 2021-03-16](https://www.keypedia.com/records/483/eli-lilly-company/9fdf10fc-bc85-478c-affd-9279176c5cb7)
- [483_RESPONSE - 2021-03-16](https://www.keypedia.com/records/483_response/eli-lilly-company/48bca0f9-fb52-4f51-9e65-4d0fd6283a21)
- [EIR - 2020-03-20](https://www.keypedia.com/records/eir/eli-lilly-company/9e8da9ed-234b-4013-bd23-c71b99acb878)

## Related Officers

- [U.S. Food and Drug Administration](https://www.keypedia.com/people/myra-k-casey/a2fae714-2ba3-4c60-9f54-990fc7b169c9)
- [Charles J. Chacko](https://www.keypedia.com/people/charles-j-chacko/91b779f7-62f5-455e-89b1-f1da3800bffd)
- [Investigator](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)
- [Program Division Director](https://www.keypedia.com/people/latonya-mitchell-holmes/3156d7bc-14d2-4453-bec1-ccbb880ce12d)
- [Acting Chief Scientist](https://www.keypedia.com/people/david-g/af849da1-665f-41f4-b7d9-f48e9845d0c7)

Company: https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf